Brief: Atreca Announces Oral Presentation Of ATRC-101 Phase 1B Study Data At ASCO 2023 Annual Meeting
26/04/2023 23:16
April 26 (Reuters) - Atreca Inc BCEL.O :
* ATRECA ANNOUNCES ORAL PRESENTATION OF ATRC-101 PHASE 1B
STUDY
DATA AT ASCO 2023 ANNUAL MEETING
Source text for Eikon: ID:nGNXvhvPv
Further company coverage: BCEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atreca
See all newsBrief: Baker Bros Advisors Reports 19.99% Passive Stake In Atreca As Of Dec 31, 2023 - SEC Filing
Brief: Immunome To Acquire Antibody-Related Assets And Materials From Atreca
Brief: Atreca Says On Dec 19 Asset Sale And Other Transactions Contemplated By Agreement, Board Approved Liquidation And Dissolution Of Co
Brief: Atreca Q3 basic EPS USD -0.92
Brief: Atreca Announces Agreement To Terminate Lease And Departure Of CFO Herb Cross